Genetics Clinical Trials

Dr. Penny Hogarth with OHSU visitor

OHSU Molecular and Medical Genetics is on the leading edge of discovering new way to detect and treat genetic conditions. In collaboration with universities and hospitals across the globe, MMG is dedicated to searching for the cure and treatment of rare diseases. 

Clinical trials during COVID-19

Many studies are still ongoing throughout the COVID-19 crisis. Please reach out to the study coordinator of your particular group to determine which protocols are in place to keep our patients and staff safe. 

CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)

The purpose of this study is to learn more about how people with the condition pantothenate kinase-associated neurodegeneration (PKAN) respond to a specialized study product. We are hoping to find out if the study product is safe, what effects—good and bad—the study product causes, and whether the study product changes certain measures of PKAN disease. Learn more.

SPARK for Autism

As autism is a spectrum, researchers need many people with autism to participate in all types of research. Until now, only a small number of individuals and families affected by autism have ever participated in research. SPARK wants to invite the entire autism community to dramatically expand its participation.

SPARK will provide researchers with medical and genetic information from tens of thousands of individuals and families affected by autism. These data will power important new research that aims to advance the understanding of autism and provide meaningful information and resources to participants. Contact the OHSU SPARK staff at SPARK@ohsu.edu or visit www.sparkforautism.org if you have any questions